This year, Olon's Daptomycin celebrates its 10th anniversary—and the API supplier group has announced the doubling of its production to meet and exceed global demand for the active ingredient.
Mylan's Generic Daptomycin Receives Approval in US
Enforcement Report - Week of March 8, 2023
Enforcement Report - Week of February 22, 2023
Enforcement Report - Week of January 25, 2023
Aspiro's Generic Daptomycin Receives Approval in the U.S.
Accord Healthcare Inc. Issues Nationwide Voluntary Recall of Daptomycin for Injection 500 mg/vial and Daptomycin for Injection 350 mg/vial Lot # R2200232 Due to Product Mix-up
Having spent the past few months combing through the data from a Phase III trial that it stopped for futility, ContraFect concluded that it still hasn’t gotten to the bottom of whether its antibiotic works in a type of staph infection.
Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today that data from the successfully completed phase 3 ERADICATE study1, evaluating ceftobiprole in the treatment of adult patients with bacterial bloodstream infections caused by Staphylococcus aureus, (SAB), have been presented at the scientific conference, IDWeek 2022, which took take place in Washington, D.C. from 19 to 23 October.
Aspiro's Generic Daptomycin Receives Approval in the U.S.